b12 injections and omeprazole POCCO (Omeprazole 40 IV Injection 1 Vial + Diluent) Gastroloc Injection 40mg(Omeprazole) x1vial |
Description
Research Beyond Fat Metabolism While AOD9604's primary research focus remains fat metabolism, the literature extends into a few adjacent areas: Cartilage and joint tissue

Subcutaneous planning from a 50 mg vial reconstituted with 3.0 mL BAC water (~16.7 mg/mL) Phase Days 12 (tolerance) Daily dose 2.5 mg once daily Units on U-100 syringe 15 units Volume 0.15 mL Phase Days 3+ (standard) Daily dose 5 mg once daily Units on U-100 syringe 30 units Volume 0.30 mL Phase Split option (BID) Daily dose 2.5 mg twice daily Units on U-100 syringe 15 units each Volume 0.15 mL each Subcutaneous doses are much smaller than oral doses because of injection volume limits and because direct subQ absorption skips the gut
/https%3A%2F%2Fopengraph.b-cdn.net%2Fproduction%2Fimages%2F2ed46913-f157-43c3-9418-19fea49af16c.png%3Ftoken%3DUl4O1QAtXTaMUjOfpBooUL-C8jajM-YwYFPrjCtr6ms%26height%3D1080%26width%3D1080%26expires%3D33315971423/og.png)
Your journey to better health and confidence starts with staying informedfollow Promed Health & Derma on Facebook, Instagram, and TikTok now to take the next step toward a healthier, happier you

This compound is not approved for medical use and must be handled only in controlled research environments using appropriate laboratory safety procedures